Stem Cell Congress 2013
4th & 5th November 2013, London
Over 200 delegates working in Stem Cell Research, Bioprocessing and Manufacturing
Over 25 presentations, case studies and panel discussions by leading biotech companies, global pharma organisations and internationally renowned academic institutions
Including 2 interactive streams:
• Stem Cells as a Tool in Discovery and Development
• Stem Cell & iPSC Bioprocessing and Manufacturing
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities
Oxford Global Conferences are proud to present our Stem Cell Congress, to be held on the 4th & 5th November 2013 at the Copthorne Tara Hotel London Kensington.
Experts predict that the stem cell industry will to be worth over $5 billion by 2014, reflecting the enormous potential of stem cell technologies in the pharmaceutical industry. Over this two day conference our esteemed experts will offer invaluable insights into the latest stem cell applications in translational research as well as exploring advances in bioprocessing and engineering technologies.
On day one our experts will explore the latest applications of stem cells in discovery and early development. Our renowned speakers will discuss methods of improving drug screening efficiency with stem cell models. Presentations will include the use of pluripotent stem cells in disease modelling, the application of iPSCs in translational research as well as stem cell based systems for gene expression profiling.
Day two will focus on overcoming bioprocessing and manufacturing challenges presented by stem cells and iPS cells. Our industry leaders will discuss promising strategies to meet cell manufacturing quality and quantity requirements. Delegates will also hear about the latest advances in reprogramming techniques and methods to ensure controlled stem cell growth.
The Stem Cell Congress is part of the highly successful Oxford Global Proteins Series. For more information on other events in the series, please see the details below:
• 2nd Annual Cell Culture & Bioprocessing Congress 4-5 November 2013, London
www.cellculture-congress.com • 7th Annual Proteins Congress, 25-26 March 2014, London, UK
www.proteins-congress.com • 2
nd Annual Biosimilars & Biobetters Congress, 25-26 March 2014, London, UK
www.biosimilars-congress.com
Agenda
The Event
In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 20 speakers will present a full conference programme covering the topics outlined below.
Day 1 – Stem Cells as a Tool in Discovery and Development
• Improving drug screening efficiency with stem cell models
• High-content and high-throughput screening tools for stem cell research
• Stem cells for toxicity and safety studies
• Application of iPSC in translational research
• The use of pluripotent stem cells in disease modelling
• Stem cell based systems for gene expression profiling
• Collaborative methods to accelerate iPSC research
Day 2 – Stem Cell & iPSC Bioprocessing and Manufacturing
• Cell manufacturing: meeting quality, quantity and safety requirements
• Overcoming upstream and downstream process challenges
• Stem cell engineering: ensuring automation and validation
• Reprogramming and transdifferentiation techniques
• Ensuring controlled growth and differentiation
• Cell banking to preserve stem cell lines
• Developing 3D tissue culture technology
Who will attend
The Stem Cell Congress is an exclusive event consisting of world-class keynote addresses, presentations and panel discussions designed specifically for senior level attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, CRO and solution provider companies, along with highly esteemed members of academic and government institutions. Delegates typically include VPs, Directors, Managers and Heads of:
|
Cell Biology
Cell Process Development
Drug Discovery Technologies
Embryonic Stem Cells
iPS Cells
Pluripotent Stem Cell Biology
Regenerative Medicine |
Stem Cell Bioprocessing
Stem Cell Engineering
Stem Cell Manufacturing
Stem Cell Research
Stem Cell Safety
Stem Cell Technologies
Toxicity and Safety Testing |
Delegates will benefit from:
• An executive format providing intimate interaction with industry peers’ ideas and experiences through case study presentations and panel discussions
• Networking opportunities and sharing ideas with other senior peers
• Pre-scheduled one-to-one meetings between you and solution providers will provide you with an opportunity to forge partnerships and discover solutions
• Post event follow up offering all documentation from the meeting and re-booking discounts
• Tailor-made agenda – hand pick any conference and panel sessions you wish to attend
Who is speaking
Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.
If you have a cutting edge case study or relevant presentation and would like to join the speaker panel at one of our events, please contact Arti Pau at
a.pau@oxfordglobal.co.uk
2013 Speakers
|
Wojtek Auerback
Senior Director Stem Cells Technologies, Regeneron Pharmaceuticals Inc
Joaquim Cabral
Professor of Biochemical Engineering, Technical University of Lisbon
ZhanFeng Cui
Professor, Oxford University
Chris Denning
Professor of Stem Cell Biology, University of Nottingham
Lauren Drawley
Associate Principal Scientist, AstraZeneca
Benjamin Fryer
Benjamin Fryer, Senior Scientist, Janssen Research & Development LLC, A Johnson & Johnson company
Gary Gintant
Research Fellow, Dept. Integrative Pharmacology, Abbvie
Alex Gutteridge
Principle Scientist, Pfizer Neusentis
Christopher Hewitt
Professor of Biological Engineering, Loughborough University
Roberto Iacone
Head Stem Cells Group, F. Hoffman-La Roche AG
Arnaud Lacoste
Project Team Leader, Stem Cells & Regenerative Medicine, Novartis
John Masters
Professor of Experimental Pathology, University College London
Theo Meert
Senior Director CREATe, Janssen Pharmaceutica R&D, Johnson and Johnson
Ali Mobasheri
Associate Professor and Reader in Comparative Physiology, University of Nottingham
Molly Stevens
Professor of Biological Materials & Regenerative Medicine, Imperial College London
David Tosh
Professor of Stem Cell & Regenerative Biology, University of Bath
Martin Zenke
Professor of Cell Biology, RWTH Aachen University |
Contact Us
Kathryn Randall
Events and Marketing Assistant
Oxford Global
Main Office: +44 (0)1865 248455
Fax: +44 (0)1865 250985
中文
